Astrana Health, Inc. (NASDAQ:ASTH) Given Consensus Rating of “Hold” by Analysts

Shares of Astrana Health, Inc. (NASDAQ:ASTH) have earned an average recommendation of “Hold” from the ten brokerages that are presently covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and five have issued a buy rating on the company. The average twelve-month price objective among brokers that have covered the stock in the last year is $50.50.

Several brokerages have weighed in on ASTH. Weiss Ratings reissued a “hold (c-)” rating on shares of Astrana Health in a report on Saturday, September 27th. Zacks Research downgraded Astrana Health from a “strong-buy” rating to a “strong sell” rating in a report on Monday, September 1st.

Institutional Investors Weigh In On Astrana Health

Several institutional investors have recently added to or reduced their stakes in ASTH. Bank of America Corp DE boosted its holdings in Astrana Health by 44.2% in the fourth quarter. Bank of America Corp DE now owns 97,721 shares of the company’s stock worth $3,081,000 after acquiring an additional 29,971 shares in the last quarter. Two Sigma Investments LP acquired a new stake in shares of Astrana Health during the fourth quarter worth about $466,000. Squarepoint Ops LLC acquired a new stake in shares of Astrana Health during the fourth quarter worth about $1,208,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in shares of Astrana Health by 15.6% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 104,658 shares of the company’s stock worth $3,300,000 after purchasing an additional 14,138 shares during the period. Finally, GAMMA Investing LLC lifted its holdings in shares of Astrana Health by 5,794.8% during the first quarter. GAMMA Investing LLC now owns 12,497 shares of the company’s stock worth $403,000 after purchasing an additional 12,285 shares during the period. Institutional investors and hedge funds own 52.77% of the company’s stock.

Astrana Health Stock Performance

Shares of Astrana Health stock opened at $28.75 on Friday. The firm has a market cap of $1.61 billion, a P/E ratio of 56.37, a P/E/G ratio of 0.71 and a beta of 0.80. The company has a current ratio of 1.59, a quick ratio of 1.59 and a debt-to-equity ratio of 0.52. Astrana Health has a 12 month low of $21.20 and a 12 month high of $63.20. The stock’s fifty day moving average price is $28.29 and its 200-day moving average price is $27.87.

Astrana Health (NASDAQ:ASTH) last announced its quarterly earnings results on Thursday, August 7th. The company reported $0.19 EPS for the quarter, missing the consensus estimate of $0.36 by ($0.17). Astrana Health had a net margin of 1.04% and a return on equity of 3.43%. The firm had revenue of $654.81 million for the quarter, compared to analysts’ expectations of $639.13 million. During the same quarter in the prior year, the business posted $0.40 EPS. The business’s quarterly revenue was up 34.7% on a year-over-year basis. Astrana Health has set its Q3 2025 guidance at EPS. On average, equities research analysts expect that Astrana Health will post 1.15 earnings per share for the current fiscal year.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.